Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal

References

• LeeWLChaoHTChengMHWangPHRationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal womenMaturitas2008609210718534794
   PubMed Web of Science ®Google Scholar
• LeeWLChaoHTChengMHWangPHThe role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifeneTaiwan J Obstet Gynecol200847243118400579
   PubMed Web of Science ®Google Scholar
• Williams-BrownMYSalihSMXuXThe effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer riskJ Steroid Biochem Mol Biol2011126788621600284
   PubMed Web of Science ®Google Scholar
• ChoCSShinTHLimJLMoonKYKimDKChoiYWStability- enhanced solid dispersion formulation of amorphous raloxifene hydrochlorideKorean J Chem Eng20102719061909
   Web of Science ®Google Scholar
• CustodioJMWuCYBenetLZPredicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorptionAdv Drug Deliv Rev20086071773318199522
   PubMed Web of Science ®Google Scholar
• JeongEJLinHHuMDisposition mechanisms of raloxifene in the human intestinal Caco-2 modelJ Pharmacol Exp Ther200431037638515020665
   PubMed Web of Science ®Google Scholar
• BayrakELambrechtFYDurkanKYilmazOIn vitro evaluation, biodistribution in rats of radiolabeled raloxifeneAppl Radiat Isot201068333619819155
   PubMed Web of Science ®Google Scholar
• WempeMFWacherVJRubleKMPharmacokinetics of raloxifene in male Wistar–Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrinInt J Pharm2008346253717644287
   PubMed Web of Science ®Google Scholar
• GargASinghSRaoVUBinduKBalasubramaniamJSolid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rateDrug Dev Ind Pharm20093545547019048425
   PubMed Web of Science ®Google Scholar
• JagadishBYelchuriRBinduKTangiHMarojuSRaoVUEnhanced dissolution and bioavailability of raloxifene hydrochloride by co-grinding with different superdisintegrantsChem Pharm Bull20105829330020190431
   PubMed Web of Science ®Google Scholar
• JhaRKTiwariSMishraBBioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluationAAPS Pharm Sci Tech201112650657
   PubMed Web of Science ®Google Scholar
• ThakkarHNangeshJParmarMPatelDFormulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery systemJ Pharm Bioallied Sci2011344244821966167
   PubMedGoogle Scholar
• ChenYJiaXChenJWangJHuMThe pharmacokinetics of raloxifene and its interaction with apigenin in ratMolecules201058478848721088662
   PubMed Web of Science ®Google Scholar
• KimARLimSJLeeBJMetabolic inhibition and kinetics of raloxifene by pharmaceutical excipients in human liver microsomesInt J Pharm2009368374418977285
   PubMed Web of Science ®Google Scholar
• ElnaggarYSEl-MassikMAAbdallahOYSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm200938013314119635537
   PubMed Web of Science ®Google Scholar
• DateAADesaiNDixitRNagarsenkerMSelf-nanoemulsifying drug delivery systems: formulation insights, applications and advancesNanomedicine201051595161621143036
   PubMed Web of Science ®Google Scholar
• NielsenFSPetersenKBMüllertzABioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary stateEur J Pharm Biopharm20086955356218294829
   PubMed Web of Science ®Google Scholar
• ChenMLLipid excipients and delivery systems for pharmaceutical development: a regulatory perspectiveAdv Drug Deliv Rev20086076877718077051
   PubMed Web of Science ®Google Scholar
• PorterCJHPoutonCWCuineJFCharmanWNEnhancing intestinal drug solubilisation using lipid-based delivery systemsAdv Drug Deliv Rev20086067369118155801
   PubMed Web of Science ®Google Scholar
• DixitRPNagarsenkerMSSelf-nanoemulsifying granules of ezetimibe: design, optimization and evaluationEur J Pharm Sci20083518319218652892
   PubMed Web of Science ®Google Scholar
• WangLDongJChenJEastoebJLiXDesign and optimization of a new self-nanoemulsifying drug delivery systemJ Colloid Interface Sci200933044344819038395
   PubMed Web of Science ®Google Scholar
• ZhaoYWangCChowAHLSelf-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studiesInt J Pharm201038317017719732813
   PubMed Web of Science ®Google Scholar
• NepalPRHanHKChoiHKPreparation and in vitro–in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10Eur J Pharm Sci20103922423220035865
   PubMed Web of Science ®Google Scholar
• RuanJLiuJZhuDPreparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex techniqueInt J Pharm201038628229019961910
   PubMed Web of Science ®Google Scholar
• BasaliousEBShawkyNBadr-EldinSMSNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimizationInt J Pharm201039120321120214965
   PubMed Web of Science ®Google Scholar
• ParmarNSinglaNAminSKohliKStudy of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery systemColloids Surf B201186327338
   PubMed Web of Science ®Google Scholar
• GuptaSChavhanSSawantKKSelf-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluationColloids Surf A2011392145155
   Web of Science ®Google Scholar
• GhaiDSinhaVRNanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective β1-adrenoreceptor blocker TalinololNanomedicine Epub September 14, 2011
   Web of Science ®Google Scholar
• DateAANagarsenkerMSDesign and evaluation of self- nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetilInt J Pharm200732916617217010543
   PubMed Web of Science ®Google Scholar
• KaduPJKushareSSThackerDDGattaniSGEnhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS)Pharm Dev Technol201116657420088679
   PubMed Web of Science ®Google Scholar
• KallakuntaVRBandariSJukantiRVeerareddyPROral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluationPowder Technol2012221375382
   Web of Science ®Google Scholar
• US Pharmacopeial ConventionUSP 34RockvilleUSP201141134115
   Google Scholar
• JeevanaJBSreelakshmiKDesign and evaluation of self-nanoemulsifying drug delivery system of flutamideJ Young Pharm201134821607048
   PubMedGoogle Scholar
• ShanmugamSBaskaranRBalakrishnanPThapaPYongCSYooBKSolid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid luteinEur J Pharm Biopharm20117925025721550401
   PubMed Web of Science ®Google Scholar
• YangZHeXZhangYThe determination of raloxifene in rat tissue using HPLCBiomed Chromatogr20072122923317236238
   PubMed Web of Science ®Google Scholar
• WempeMFWrightCLittleJLInhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGSInt J Pharm20093709310219100824
   PubMed Web of Science ®Google Scholar
• PatelJPatelARavalMShethNFormulation and development of a self-nanoemulsifying drug delivery system of irbesartanJ Adv Pharm Technol Res2011291622171286
   PubMedGoogle Scholar
• KohliKChopraSPharDAroraSKhanRSelf-emulsifying drug delivery system: an approach to enhance oral bioavailabilityDrug Discov Today20101595896520727418
   PubMed Web of Science ®Google Scholar
• RowRCSheskeyPJWellerPJHandbook of Pharmaceutical Excipients4th edLondonPharmaceutical Press and American Pharmaceutical Association2003
   Google Scholar
• TangSYManickamSWeiTKNashiruBFormulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitationUltrason Sonochem20121933034521835676
   PubMed Web of Science ®Google Scholar
• YangZhYZhangZhFHeXBZhaoGYZhangYQValidation of a novel HPLC method for the determination of raloxifene and its pharmacokinetics in rat plasmaChromatographia200765197201
   Web of Science ®Google Scholar
• KempDCFanPWStevensJCCharacterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearanceDrug Metab Dispos20023069470012019197
   PubMed Web of Science ®Google Scholar
• MarcondesFKBianchiFJTannoAPDetermination of the estrus cycle phases of rats: helpful considerationsBraz J Biol20026260961412659010
   PubMedGoogle Scholar
• El-MasMMEl-GowillySMGoharEYGhazalARAbdel-RahmanAAEstrogen dependence of the renal vasodilatory effect of nicotine in rats: role of α7 nicotinic cholinergic receptor/eNOS signalingLife Sci20118818719321092740
   PubMed Web of Science ®Google Scholar
• FatourosDGKarpfDMNielsenFSMullertzAClinical studies with oral lipid based formulations of poorly soluble compoundsTher Clin Risk Manag2007359160418472981
   PubMedGoogle Scholar
• CelnikierDHPharmacokinetics of raloxifene and its clinical applicationEur J Obstet Gynecol Reprod Biol199985232910428318
   PubMed Web of Science ®Google Scholar